Responding to Medical Pluralism in Practice: A Principled Ethical Approach

References

1. ↵
   Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? Soc Sci Med 1997; 44(5): 681–92.

   OpenUrl
2. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making health care decisions: the ethical and legal implications of informed consent in the patient-practitioner relationship. Washington, DC: President's Commission; 1982.
3. ↵
   Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. Oxford: Oxford University Press; 2001.
4. Sugarman J. Informed consent, shared decision-making, and complementary and alternative medicine. J Law Med Ethics 2003; 31(2): 247–50.

   OpenUrl
5. ↵
   Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; (343): 1–19.

   OpenUrlPubMed
6. ↵
   Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280(18): 1569–75.

   OpenUrl
7. ↵
   Institute of Medicine. Complementary and alternative medicine in the United States. Washington, DC: National Academies Press; 2005.
8. ↵
   Cassileth BR, Lucarelli CD. Herb-drug interactions in oncology. New York: BC Decker; 2003.
9. ↵
   Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127(1): 61–9.

   OpenUrl
10. ↵
    Callahan D, ed. The role of complementary and alternative medicine: accommodating pluralism. Washington, DC: Georgetown University Press; 2002.
11. ↵
    Cohen MH, Eisenberg DM. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med 2002; 136(8): 596–603.

    OpenUrl
12. ↵
    Adams KE, Cohen MH, Eisenberg D, Jonsen AR. Ethical considerations of complementary and alternative medicine therapies in conventional medical settings. Ann Intern Med 2002; 137: 660–64.

    OpenUrlPubMedWeb of Science
13. ↵
    International Iridology Practitioner's Association. Frequently asked questions. Pinehurst (TX): IIPA [cited 2006 March 1]. Available from: http://iridologyassn.org/faqs.
14. ↵
    Munstedt K, El-Safadi S, Bruck F, Zygmunt M, Hackethal A, Tinneberg HR. Can iridology detect susceptibility to cancer? A prospective case-controlled study. J Alter Complement Med 2005; 11(3): 515–19.

    OpenUrl
15. ↵
    Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003; 95(11): 830–31.

    OpenUrl
16. ↵
    Fetters M, Churchill LR, Danis M. Conflict resolution at the end of life. Crit Care Med 2001; 29: 921–25.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Cui Y, Shu X, Gao Y, Hui C, Tao M, Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 2006; 163(7): 645–53.

    OpenUrl
18. ↵
    Kaptchuk TJ. The placebo effect in alternative medicine: can performance of a healing ritual have clinical signficance? Ann Intern Med 2002; 136: 817–25.

    OpenUrlPubMedWeb of Science
19. ↵
    Miller FG, Emanuel EJ, Rosenstein DL, Straus SE. Ethical issues concerning research in complementary and alternative medicine. JAMA 2004; 291(5): 599–604.

    OpenUrl